Stock Analiz

Opko Health, Inc. (OPK) financials: revenue, earnings and cash flow

Fiscal 2016–2025 + TTM · from SEC filings · data as of November 13, 2026

Summary

Opko Health’s revenue went from $1.2B in fiscal 2016 to $607M in fiscal 2025, a decline of about 7.5% a year.

Net income in fiscal 2025 was -$226M, a net margin of -37.2%; the best year in this period was 2020 with $31M.

Over the twelve months to September 30, 2026, revenue was $654M and net income -$148M.

Free cash flow was -$191M in fiscal 2025 and positive in 3 of the 10 years shown.

The diluted share count rose 35% over the period (dilution).

Revenue, profit and cash flow by year

Revenue
2016: $1.2B162017: $1.1B172018: $990M182019: $902M192020: $1.4B202021: $1.8B212022: $1.0B222023: $863M232024: $713M242025: $607M25$607M
Net income
2016: -$48M162017: -$305M172018: -$153M182019: -$315M192020: $31M202021: -$30M212022: -$328M222023: -$189M232024: -$53M242025: -$226M25-$226M
Free cash flow
2016: $13M162017: -$139M172018: -$137M182019: -$185M192020: $6M202021: $6M212022: -$120M222023: -$44M232024: -$208M242025: -$191M25-$191M
EPS (diluted)
2016: $-0.10162017: $-0.55172018: $-0.27182019: $-0.53192020: $0.05202021: $-0.05212022: $-0.46222023: $-0.25232024: $-0.08242025: $-0.3025$-0.30

Income statement

Fiscal yearTTM2025202420232022202120202019201820172016
Revenue$654M$607M$713M$863M$1.0B$1.8B$1.4B$902M$990M$1.1B$1.2B
Gross profit$284M$206M$219M$318M$288M————$1.0B$658M
Operating income-$88M-$117M-$152M-$157M-$226M$19M$58M-$274M-$171M-$276M-$97M
Net income-$148M-$226M-$53M-$189M-$328M-$30M$31M-$315M-$153M-$305M-$48M
EPS (diluted)$-0.19$-0.30$-0.08$-0.25$-0.46$-0.05$0.05$-0.53$-0.27$-0.55$-0.10
R&D$128M$124M$105M$90M$74M$77M$75M$118M$126M$126M$114M
Revenue growth—−14.9%−17.4%−14.0%−43.4%+23.6%+59.2%−8.9%−7.2%−12.6%+148.4%

Cash flow

Fiscal yearTTM2025202420232022202120202019201820172016
Operating cash flow-$125M-$179M-$183M-$28M-$95M$38M$39M-$173M-$109M-$92M$32M
Capital spending-$10M-$12M-$25M-$16M-$25M-$32M-$34M-$13M-$28M-$47M-$19M
Free cash flow-$135M-$191M-$208M-$44M-$120M$6M$6M-$185M-$137M-$139M$13M
Dividends paid———————————
Buybacks$42M$47M$90M$0$0——————
Stock-based pay$10M$11M$11M$11M$19M$14M$9M$13M$22M$28M$43M

Balance sheet

Fiscal yearTTM2025202420232022202120202019201820172016
Cash—$364M$427M$96M$153M$135M$72M$85M$96M$91M$169M
Debt—$394M$502M$77M$296M$260M$290M$310M$11M$13M$13M
Equity—$1.3B$1.4B$1.4B$1.6B$1.7B$1.7B$1.6B$1.8B$1.8B$2.0B
Total assets—$1.9B$2.2B$2.0B$2.2B$2.4B$2.5B$2.3B$2.5B$2.6B$2.8B
Shares (diluted)746M751M694M752M719M648M641M595M563M559M556M

Margins and returns

Fiscal yearTTM2025202420232022202120202019201820172016
Gross margin43.4%33.9%30.6%36.8%28.7%————94.3%53.8%
Operating margin-13.4%-19.4%-21.3%-18.2%-22.5%1.1%4.0%-30.4%-17.3%-25.9%-7.9%
Net margin-22.6%-37.2%-7.5%-21.9%-32.7%-1.7%2.1%-34.9%-15.4%-28.6%-4.0%
FCF margin-20.7%-31.4%-29.2%-5.1%-11.9%0.4%0.4%-20.5%-13.8%-13.0%1.1%
ROIC—-6.6%-6.4%-8.5%-10.2%0.8%1.9%-11.2%-7.4%-11.8%-3.7%
ROE—-17.8%-3.9%-13.6%-21.0%-1.8%1.8%-19.5%-8.5%-16.6%-2.4%

Frequently asked questions

What is Opko Health’s annual revenue?

$607M in fiscal 2025 and $654M over the twelve months to September 30, 2026.

How much profit does Opko Health make?

Net income was -$226M in fiscal 2025 (net margin -37.2%).

Is Opko Health’s revenue growing?

No: revenue fell 14.9% in fiscal 2025 compared with the year before.

From the company’s 10-K and 10-Q filings with the SEC; per-share figures adjusted for stock splits. Rebuilt daily. Not investment advice.